Elizabeth Mullen, MD
Dana-Farber Cancer Institute
Identification of Clinical Biomarkers of Wilms Tumor Using High Accuracy Mass Spectroscopy Urine Proteome Profiling

Read About Dr. Mullen's Findings
Awarded in 2011, 2012
Dana-Farber Cancer Institute
Identification of Clinical Biomarkers of Wilms Tumor Using High Accuracy Mass Spectroscopy Urine Proteome Profiling